TGFB1 and neoplasm: Patients in our study with high post-CRT plasma TGF-β1 levels were more prone to tumor progression, which agrees with previous results [21, 22], showing that post-CRT TGF-β1 levels indicate tumor immune escaping, leading to tumor progression.